Experience the speed and accuracy of molecular diagnostics across institutions of any size, from small clinics to high-volume hospitals, with Anbio’s comprehensive RT-PCR solution. Anbio’s molecular diagnostic test menu offers the most innovative diagnostic solutions, with a variety of clinical applications including healthcare-associated infections, critical infectious diseases, sexual health, virology, pharmacogenomics and oncology. Embrace the power of teamwork and explore the latest diagnostic breakthroughs with Anbio.
At Anbio, we are pioneering the field of molecular diagnostics (MDx) with our reagent kits for quantitative reverse transcriptase PCR (qRT-PCR). Our kits offer seamless integration into existing workflows, are compatible with a wide range of RT-PCR readers, and can be tailored to meet the needs of even the most demanding assays.
For healthcare providers, our pharmacogenomic assays provide essential insight into the impact of genetic variations on patient response to drugs, equipping them to prescribe the most suitable treatment option. By providing a comprehensive portfolio of RT-PCR tests for personalized medicine, Anbio is ushering in a new era of MDx.
At Anbio, our mission is to provide healthcare providers with a cost-effective and comprehensive molecular RT-PCR solution. Our RT-PCR solution offers rapid, precise, and reliable results for a wide variety of analytes, equipping healthcare providers with the ability to diagnose patients quickly and accurately. Jack Davis, our Chief Business Officer, says: “Our RT-PCR solution is designed to help healthcare professionals deliver the best possible care to their patients.”
About Anbio Biotechnology
At Anbio Biotechnology, we are passionate about improving human health. To this end, we strive to innovate in life sciences by working in close partnership with global research institutes. Our dedication to technical advancement has enabled us to develop a comprehensive range of clinical diagnosis products, including laboratory and point-of-care solutions. We are thrilled to use cutting-edge technology to contribute to meaningful medical progress.